IS LAB




MLS 412 Immunology & Serology — High-Yield Exam Reviewer


EVACUATED TUBE SYSTEM (ETS)

Vein Priority: Median Cubital (1st) → Cephalic (2nd) → Basilic (3rd/last resort, near basilic artery)

Key Steps to Remember:

  • Tourniquet: <1 min to avoid hemoconcentration (darker blood)

  • Release tourniquet when backflow is established

  • Bevel facing up on needle insertion

  • Mix additive tubes: 3–8 gentle inversions

  • Label tubes before leaving bedside

  • Discard needle + holder as a unit into sharps container (red)

Order of Draw: Blood cultures → Light Blue (SPS) → Red → SST → PST → Green → Lavender/EDTA → Gray Mnemonic: "Be careful, Stop Light, Red, Stay, Put, Green, LEts, Go"

Special Handling:

  • Ammonia → crushed ice

  • Cold agglutinin → body temperature

  • Bilirubin → protect from light (photosensitive)

Dietary Requirements:

  • FBS: 8–10 hrs

  • Lipid Profile: 10–12 hrs

  • FBS + LP: 10 hrs


SERUM DILUTION

Formula: Dilution = Volume of Solute / Total Volume

Simple Dilution: single step reduction

  • Dilution factor = denominator (whole number)

  • Example: 1:20 dilution of 2 mL → Serum = 0.1 mL; Diluent = 1.9 mL

Serial Dilution: stepwise, consistent factor each step

  • Most common: two-fold (doubling) dilution

  • Used to determine titer (strength of antibody)

  • Final dilution = product of all individual dilutions


BASIC SEROLOGICAL PRINCIPLES

Serology: identifies/measures antigens, antibodies using body fluids (mainly serum)

Key Terms:

  • Affinity: strength of ONE antibody site + ONE epitope

  • Avidity: OVERALL strength of multiple binding sites (IgM has highest avidity — 10 binding sites)

  • Cross-reactivity: antibody binds structurally similar antigen (e.g., cowpox/smallpox)

  • Paratope: antibody determinant (binds antigen)

  • Epitope: antigen determinant (binds antibody)

  • Sensitization: Ag+Ab bind, NO visible reaction (Step 1)

  • Lattice formation: visible agglutination (Step 2)

  • Titer: highest dilution showing POSITIVE result

  • Seroconversion: antibodies start to APPEAR

  • Seroreversion: antibodies start to DISAPPEAR

Factors Influencing Ag-Ab Reactions:

  • pH: 6.8–7.0 (near physiological)

  • Temperature: IgM → 4–27°C (colder = igMalamig); IgG → 30–37°C (warmer = igGang)

  • Concentration: Zone of equivalence = best reaction

    • Prozone: excess antibody → false negative

    • Postzone: excess antigen → false negative

  • Centrifugation: catalyst, speeds up lattice formation

Immunoglobulin Abundance: IgG > IgA > IgM > IgD > IgE (GAMDE)

Primary vs. Secondary Immune Response:

Feature

Primary

Secondary

Lag Phase

Longer

Shorter

Antibody Isotype

IgM then IgG

Predominantly IgG

Titer

Lower

Higher

Duration

Short-lived

Long-lasting


PRECIPITATION TECHNIQUES

Precipitation: soluble antigen + soluble antibody = insoluble complex

Turbidimetry: measures REDUCTION in light intensity (detector in line with light)

Nephelometry: measures SCATTERED light at 10–90° angle; amount scattered = index of concentration

Rate Nephelometry: measures rate of increase in light scattering after antibody is added

Radial Immunodiffusion (RID):

  • Single diffusion; antibody in gel, antigen diffuses

  • Product: precipitation ring

  • Bigger diameter = higher antigen concentration

  • Mancini (Endpoint): diameter² ∝ concentration (measure after diffusion complete)

  • Fahey (Kinetic): diameter ∝ log concentration (measure during diffusion)

  • Mnemonic: Fahey = Kinetic; Mancini = Endpoint (James RID FAKME)

Ouchterlony Double Immunodiffusion:

  • Both antigen AND antibody diffuse

  • Product: precipitation lines

  • Identity → smooth arc

  • Nonidentity → lines cross

  • Partial identity → spur formation


AGGLUTINATION

Agglutination Stages:

  1. Sensitization (rapid, reversible, no visible reaction)

  2. Lattice formation (visible clumping)

Types:

Type

Antigen

Detects

Example

Direct

Naturally on cell

Ab or Ag

Blood typing

Hemagglutination

Natural RBC antigens

Ab

ABO typing

Passive (Indirect)

Coated on carrier

Antibodies

CRP, RF, ASO

Reverse Passive

Antibody on carrier

Antigens

RPR

Coagglutination

Protein A on S. aureus Fc

Antigens

S. aureus Ag

Viral Hemagglutination

Viral RBC receptors

Antigens

Influenza

Agglutination Inhibition

Haptens on carrier

Antigen (by inhibition)

Pregnancy test

Hemagglutination (Blood Typing):

Blood Type

Antigen

Antibody

A

A

Anti-B

B

B

Anti-A

AB

AB

None

O

None

Anti-A & Anti-B

Forward Typing: packed RBC + known antibody → detect ANTIGEN

  • Blue = Anti-A; Yellow = Anti-B; Colorless = Anti-D

Reverse Typing: patient plasma + known RBCs → detect ANTIBODY

Coagglutination: Protein A binds Fc region of IgG; antigen binds FAB region

Agglutination Inhibition:

  • Successful inhibition = POSITIVE

  • Unsuccessful inhibition = NEGATIVE

Hemagglutination Inhibition: absence of agglutination = antibody present = POSITIVE


COMPLEMENT FIXATION TEST

Stage 1: Antigen + Patient Serum → if antibodies present → complement is FIXED/consumed

Stage 2: Add sensitized sheep RBCs

  • Positive (Ab present): complement consumed → NO hemolysis (no lysis of RBCs)

  • Negative (No Ab): free complement available → HEMOLYSIS occurs

Counterintuitive: No hemolysis = POSITIVE

Heat inactivation: 56°C for 30 minutes


LABELED IMMUNOASSAYS

Competitive: labeled vs unlabeled antigen compete for limited Ab sites

  • More patient antigen → less label bound → LOWER signal

  • Inverse relationship: signal ↑ = antigen ↓

Noncompetitive (Sandwich): antibody excess; signal directly proportional to antigen concentration

Heterogeneous: requires separation step Homogeneous: no separation step; faster but less sensitive

ELISA Types:

  • Direct: primary antibody with label

  • Indirect: secondary labeled antibody

  • Sandwich/Capture: antigen between two antibodies

  • Competitive: labeled vs unlabeled antigen

Radioimmunoassay (RIA): uses radioactive label (¹²⁵I most popular)

  • RIST: measures total serum IgE

  • RAST: detects allergen-specific IgE

Immunofluorescence:

  • Direct IFA: fluorescent antibody added to unknown antigen on slide; best for antigen detection

  • Indirect IFA: patient serum + known antigen → anti-human Ig with fluorescent tag; best for antibody identification


C-REACTIVE PROTEIN (CRP)

Nature: pentraxin family (5 subunits); synthesized by hepatocytes; increases up to 1000-fold in inflammation

Stimulated by: IL-6 (from activated macrophages/monocytes)

Principle: Reverse Passive Agglutination

  • Unknown: CRP (antigen)

  • Known: latex particles coated with anti-CRP antibody (polystyrene)

  • Agglutination = CRP > 6 IU/mL = POSITIVE

CRP Elevated In: viral/bacterial infections, gout, RA, myocardial infarction, acute rheumatic fever

Note: CRP does NOT spike significantly in SLE or RA (autoimmune conditions)

Specimen: red-top or gold-top tube; no fasting required

  • Reject: lipemia, hemolysis, bacterial contamination

  • Refrigerate: 2–8°C up to 24 hrs; freeze at –20°C longer

Qualitative (Screening): agglutination = CRP > 6 IU/mL → proceed to semi-quantitative

Semi-Quantitative Conversion: titer × 6 = CRP in mg/L

  • Example: titer 1:4 → 4 × 6 = 24 mg/L


RHEUMATOID FACTOR (RF)

Disease: Rheumatoid Arthritis (RA) — systemic autoimmune disorder; destroys bone/cartilage

Key Features:

  • Pannus formation (invasive granulation tissue in joints)

  • Osteoclast overactivation → bone erosion

  • TNF-α regulates osteoclast/osteoblast balance

Two Key Antibodies:

  • RF (IgM): directed against Fc portion of IgG; not specific (also in SLE, Sjögren's, syphilis, hepatitis)

  • Anti-CCP: better and more specific than RF for RA

Principle: Passive Agglutination

  • Unknown: Rheumatoid Factor (antibody)

  • Known: latex particles coated with human IgG (antigen)

  • Agglutination = RF present

Strongest environmental risk: cigarette smoking (doubles risk)

Specimen: same as CRP (red-top, no fasting)

  • Reagent color: WHITE (vs CRP = Blue; ASO = Yellow)

Semi-Quantitative: titer × 12 = RF in IU/mL (some kits use factor 20)

  • Example: 1:4 → 4 × 12 = 48 IU/mL; OR 4 × 20 = 80 IU/mL


ANTISTREPTOLYSIN O (ASO)

Causative Agent: Group A Streptococcus (Streptococcus pyogenes)

Virulence Factors:

  • Protein F → attachment

  • Hyaluronic acid capsule → inhibits phagocytosis (mimics host)

  • M protein → major virulence factor; antiphagocytic (board exam answer)

  • Streptolysin O → oxygen-labile; subsurface hemolysis; more destructive

  • Streptolysin S → oxygen-stable; surface hemolysis

  • Streptokinase → activates plasminogen → plasmin → dissolves clots

  • DNase → degrades DNA

  • Hyaluronidase → "spreading factor"; breaks down connective tissue

  • C5a peptidase → destroys complement chemotactic factors

  • Streptococcal pyogenic exotoxins → superantigens → cytokine storm

Sequelae (complications, NOT primary infections):

  • Rheumatic Fever (M protein mimics heart tissue → molecular mimicry)

  • Acute Post-Streptococcal Glomerulonephritis (APSGN) → antigen-antibody complex trapped in glomeruli → hematuria

ASO Test Purpose: detect PAST streptococcal infection (not current); evidence of recent Group A infection

Titer rises: 1–2 weeks post infection; peaks 3–6 weeks after symptoms

Principle: Passive Agglutination

  • Unknown: ASO antibodies (patient serum)

  • Known: latex coated with stabilized Streptolysin O

  • Agglutination = ASO present = POSITIVE

Qualitative: agglutination = ASO > 200 IU/mL Semi-Quantitative: titer × 200 = ASO in IU/mL

  • Example: 1:4 → 4 × 200 = 800 IU/mL

False negative: hemolyzed sample (free hemoglobin neutralizes streptolysin O)

  • Reagent color: YELLOW


RAPID PLASMA REAGIN (RPR) — SYPHILIS

Causative Agent: Treponema pallidum subspecies pallidum (hard chancre)

  • Haemophilus ducreyi → soft chancre (painful)

Stages of Syphilis:

  • Primary: single painless hard chancre

  • Secondary: skin rash, mucous membrane lesions, Condyloma lata

  • Latent: no symptoms (Early <12 months; Late >12 months)

  • Tertiary: rare; affects brain (Neurosyphilis), eyes (Ocular), ears (Otosyphilis)

Tests for Syphilis:

Type

Test

Purpose

Non-treponemal

RPR (qualitative only)

Screening

Non-treponemal

VDRL (qualitative + semi-quant)

Screening

Treponemal

FTA-ABS, TPHA

Confirmatory (specific)

Reagin: IgM and IgG antibodies against cardiolipin (non-specific)

RPR Principle: flocculation (larger than precipitation)

  • Antigen: cardiolipin + charcoal particles + cholesterol + lecithin

  • Unknown: reagin antibody

  • Positive: black clumps (charcoal) on white card background

Choline chloride in RPR antigen → inactivates complement → no heating needed

Report as: Reactive / Non-reactive (NOT positive/negative)

  • Any clumping = REACTIVE; smooth gray = NON-REACTIVE

Rotation: 8 minutes at 100 rpm (mechanical) + 3–4 to-and-fro motions (manual)

  • Read in "wet" state under bright light

  • Do NOT read after 20 minutes

False reactive causes: malaria, TB, pregnancy, autoimmune disorders, recent vaccination

Specimen storage: 2–8°C up to 72 hours


WIDAL TEST (TYPHOID FEVER)

Causative Agent: Salmonella enterica serotypes Typhi and Paratyphi A, B

Key Antigens:

  • O antigen (Ohne): somatic/cell wall; thermostable; shared between Typhi and Paratyphi

  • H antigen (Hauch): flagellar; thermolabile; species specific

  • Vi antigen: capsular (unique to Salmonella — NO K antigen)

  • AH antigen → specific to Paratyphi A

  • BH antigen → specific to Paratyphi B

Principle: Direct Agglutination

  • Known: killed bacterial suspension of Salmonella (antigen)

  • Unknown: patient antibodies

Widal Kit Colors:

  • Blue stained = O antigen (somatic)

  • Red stained = H antigen (flagellar)

Interpretation:

Result

Suggestive of

↑TO antibody only

Recent infection: S. Typhi OR S. Paratyphi A or B

↑TO + TH

Enteric fever: S. Typhi

↑TO + AH

Enteric fever: S. Paratyphi A

↑TO + BH

Enteric fever: S. Paratyphi B

↑TH only

Convalescent stage / Anamnestic response

All (TO, TH, AH, BH) ↑

Post TAB vaccination

Significant titer: >1:80

  • Normal individuals may show agglutination up to 1:40

O antibody: early to come, early to leave H antibody: late to come, late to leave

Four-fold rise (2 tube difference): indicates ACTIVE infection

Tube Agglutination Incubation:

  • O antigen: 48–50°C for 4 hours

  • H antigen: 48–50°C for 2 hours

  • OR 37°C for 18–20 hours

Typhidot: more specific and faster than Widal; less cross-reactivity


INFECTIOUS MONONUCLEOSIS (Monospot)

Causative Agent: Epstein-Barr Virus (EBV) = Human Herpesvirus Type 4 (HHV-4)

  • "Kissing disease" — transmitted mainly through saliva

Pathology:

  • EBV infects B lymphocytes

  • Atypical lymphocytes seen = Downey cells (reactive T cells, NOT monocytes)

  • Lymphocytes >50% WBC; >10% atypical lymphocytes

Heterophile Antibodies:

  • IgM class; non-specific

  • React with horse, ox, goat, sheep RBCs

  • Titer of 1:56 is significant

  • NOT specific to EBV

Paul-Bunnell-Davidsohn Test:

Antibody

Sheep RBCs

Guinea Pig Kidney

Beef/Ox RBCs

Forssman Ab

+

+

–

Serum Sickness Ab

+

+

+

IM (Heterophile) Ab

+

–

+

Mnemonic: GFBM — Guinea pig removes Forssman; Beef removes Mono

Principle of Monospot: Passive Agglutination

  • Latex coated with Paul-Bunnell antigen (from bovine RBC membranes)

  • Detects IM heterophile antibodies

  • Agglutination = POSITIVE

Forssman Antigen: glycolipid heterophile antigen (NOT found normally in humans); found in guinea pig, dog, cat, mouse, horse, fowl RBCs

Semi-quantitative dilutions: 1:2, 1:4, 1:8, 1:16, 1:32


DENGUE DETECTION

Causative Agent: Dengue virus (ssRNA Flaviviridae); 4 serotypes (DENV 1–4)

  • Vector: Aedes aegypti (urban; 2 silvery lines); Aedes albopictus (rural; 1 silvery line)

NS1 Antigen:

  • First viral marker to appear; detectable days 1–9 after fever onset

  • Indicates early dengue infection; does NOT identify serotype

Antibody Timeline:

  • IgM: detectable 5–10 days after onset (primary); 4–5 days (secondary)

  • IgG: appears day 14 in primary; rises 1–2 days after onset in secondary; persists for life

Result Interpretation:

Result

Interpretation

NS1+ only

Early dengue infection

IgM+ only

Primary dengue infection

IgG+ only

Secondary or past dengue infection

IgM+ + IgG+

Late primary OR early secondary

All negative

Negative (retest in 3–5 days if suspected)

No C line

INVALID

Test: Immunochromatographic assay (Bioline Dengue Duo)

  • NS1 Ag: 3 drops (100 µL) specimen

  • IgG/IgM: 10 µL specimen + 4 drops assay diluent

  • Read at 15–20 minutes (do NOT read after 20 min)

  • Any line, no matter how faint = POSITIVE

Cross-reactivity: with other Flaviviruses (West Nile, Zika, Yellow Fever, Japanese Encephalitis)


HEPATITIS

Transmission Summary:

  • A & E: fecal-oral (contaminated water) — "tAE"

  • B & C: blood/body fluids

  • D: requires HBV (defective virus)

Type

Nucleic Acid

Family

Vaccine

A

RNA

Picornaviridae

Yes

B

DNA

Hepadnaviridae

Yes

C

RNA

Flaviviridae

No

D

RNA

Deltavirus

Yes (via HBV vaccine)

E

RNA

Hepeviridae

Yes

Hepatitis B Serological Markers:

Marker

Significance

HBsAg

Active HBV infection (acute or chronic); first detectable marker

HBeAg

Active viral replication; high infectivity

HBcAg

Found in liver only (NOT in serum); core antigen

Anti-HBc (IgM)

Recent/acute infection; window period marker

Anti-HBe

Convalescent phase; seroconversion; healing

Anti-HBs

Full recovery AND immunity (also from vaccination)

HBsAg: detectable 2 weeks–2 months before symptoms; persists 2–3 months

Immunized with HBsAg: HBsAg(–), Anti-HBs(+), Anti-HBc(–) Natural immunity: HBsAg(–), Anti-HBs(+), Anti-HBc(+)

Hepatitis C: "Non-A/Non-B"; Gold standard = RT-PCR; Anti-HCV detectable 8–10 weeks post-exposure

Hepatitis D:

  • Co-infection: (+) IgM anti-HBc

  • Superinfection: (+) IgG anti-HBc

HBsAg Test Principle: Immunochromatographic Assay (sandwich)

  • Specimen: 100 µL serum/plasma

  • Read at 20 minutes


HIV

Causative Agent: RNA retrovirus; Family Retroviridae, Genus Lentivirinae

Structural Genes:

  • gag gene: encodes p24 (capsid), p17 (matrix)

  • pol gene: encodes reverse transcriptase (p66/p51), integrase (p31), protease (p10)

  • env gene: encodes gp160 → gp120 (docking/attachment) + gp41 (fusion)

Key Proteins:

  • gp120 = attachment to CD4 receptor

  • gp41 = membrane fusion

  • p24 = key early marker of infection; forms capsid

  • p17 = matrix protein (between core and envelope)

Co-receptors:

  • CXCR4 → T lymphocytes (X4 or T-tropic strains)

  • CCR5 → Macrophages (R5 or M-tropic strains)

Tip: X in CXCR4 = T cells; CC in CCR5 = Macrophages

Replication Cycle:

  1. Attachment (gp120 + CD4) → 2. Fusion (gp41) → 3. Reverse transcription (RNA→DNA) → 4. Integration (provirus) → 5. Replication → 6. Assembly → 7. Budding + Protease cleavage → mature virion

Stages of HIV:

Stage

CD4 Count

Feature

1: Acute

>500 cells/µL

Flu-like symptoms; high viral load

2: Chronic

200–499 cells/µL

Asymptomatic; clinical latency

3: AIDS

<200 cells/µL

Opportunistic infections

Normal CD4:CD8 ratio = 2:1; In AIDS = <0.5:1 (inverted)

Transmission (most to least common): Sexual contact → Parenteral → Vertical (perinatal)

  • NOT transmitted by saliva

ART Drug Classes:

  • Entry inhibitors (block CCR5 binding)

  • Fusion inhibitors (block gp41 fusion)

  • Reverse transcriptase inhibitors (block RNA→DNA)

  • Integrase inhibitors (block provirus integration)

  • Protease inhibitors (block protein cleavage)

Lab Diagnosis Algorithm (CDC 2014):

  1. Screening: 4th-generation ELISA (detects HIV-1/2 Ab + p24 Ag simultaneously)

  2. Differentiation: Geenius HIV 1/2 Supplemental Assay (replaces Western Blot)

  3. Confirmatory/Early: Nucleic Acid Testing (NAT/HIV RNA) — detectable by day 10

First markers to appear (in order): HIV RNA → p24 antigen → HIV IgM → HIV IgG → Western Blot bands

Western Blot Positive: ≥2 of these 3 bands: p24, gp41, gp120/160

  • p24 + gp41 = POSITIVE

  • gp41 alone = INDETERMINATE

Geenius HIV 1/2:

  • HIV-1 positive: reactivity to gp160 + gp41 OR 1 envelope + p24 or p31

  • HIV-2 positive: reactivity to BOTH gp36 AND gp140

Philippine rHIVda: T1 (screening) → T2 → T3 (Geenius); all 3 positive = HIV confirmed

Disease Monitoring:

  • CD4 count: best indicator of immune function; done by flow cytometry

  • Viral load (HIV RNA copies/mL): monitors ART effectiveness; goal = undetectable

U = U: Undetectable = Untransmittable


ACUTE PHASE REACTANTS (CRP topic)

Positive APR (increase): CRP, Fibrinogen, Haptoglobin, Ceruloplasmin, Complement C3/C4, Serum Amyloid A, Anti-chymotrypsin

Negative APR (decrease): Albumin (most abundant blood protein), Transferrin, Alpha-fetoprotein

Regulated by: IL-6, IL-1, TNF-α (pro-inflammatory cytokines) Produced by: Liver (hepatocytes)

Systemic Response Categories:

  • Neuroendocrine: fever, HPA axis activation (CRH→ACTH→cortisol)

  • Metabolic: muscle breakdown, ↑CPK

  • Hematologic: leukocytosis, thrombocytosis, anemia

  • Biochemical: ↓Fe, ↓Zn, ↑Cu


QUICK COMPARISON TABLE: CRP vs RF vs ASO

Feature

CRP

RF

ASO

What detected

Antigen (CRP)

Antibody (RF)

Antibody (ASO)

Principle

Reverse Passive

Passive Agglutination

Passive Agglutination

Known reagent

Anti-CRP Ab on latex

Human IgG on latex

Streptolysin O on latex

Reagent color

Blue

White

Yellow

Positive threshold

>6 IU/mL

>20 IU/mL

>200 IU/mL

Conversion factor

×6

×12 (or ×20)

×200

Tube used

Red/Gold top

Red/Gold top

Red/Gold top

Fasting required

No

No

No

Reject specimens

Lipemia, hemolysis, bacteria

Same

Same + hemolysis causes false negative


AGGLUTINATION INHIBITION vs HEMAGGLUTINATION INHIBITION


Agglutination Inhibition

Hemagglutination Inhibition

Positive result

NO agglutination (inhibited)

NO agglutination

Detects

Antigen

Antibody

Example

Pregnancy test

Viral Ab test


Good luck on your exams! Fighting and Faithing!